Sophie Shotter and Hernán Pinto examine whether autologous exosomes are a durable advance in aesthetic medicine or a passing trend, weighing the available evidence against the claims circulating in the field. The discussion covers what “exosome” means biologically and in regulatory terms, and what an autologous, point-of-care source changes.
SPEAKERS
Sophie Shotter, MD
Hernán Pinto, MD, PhD, MSc
Moderated by Laura Cordero, PhD, MSc
